DPI Research Academy

  A new market intelligence report released by DPI Research with the title “ Global Influenza Vaccines Market 2021 – 2027 ” is designed to cover micro-level analysis by manufacturers and key business segments. The Global Influenza Market analysis offers active visions to conclude and study the market size, trends, growth, demand, revenue, market share by company, and competitive backgrounds. This report also provides SWOT Analysis with potential market opportunities for assessing the Overall Market, underlining opportunities, and supporting strategic and tactical decision-making for companies and individuals. Some of the key players profiled in the study are Sanofi Pasteur, GlaxoSmithKline (GSK), Seqirus (CSL Limited), AstraZeneca, Mylan, BioDiem, Novavax, Medicago, Moderna Inc, Pneumagen, Daiichi–Sankyo, Altimmune, FluGen, Imutex, EpiVax, Versatope Therapeutics, Inc., Gamma Vaccines Pty Ltd., BiondVax Pharmaceuticals Ltd., Hualan Biological Engineering Inc., Shanghai Institute of Biol

Global Influenza Vaccines Market 2021 - 2027 | DPI Research : Global Influenza Vaccines Market 2021 – 2027 The number of persons being vaccinated with influenza vaccines worldwide will touch the figure of 500 Million by the year-end of 2027. Market growth can be attributed to factors such as increased disease awareness, expanded recommendations by governmental and advisory bodies to be vaccinated against influenza vaccines, the introduction of quadrivalent influenza vaccines, increase in the size of the elderly population in most of the countries.

DPI Research published a new report, titled, “United States Insulin Injection Pen Market” The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segment, Porter’s Five Forces analysis, and competitive landscape. This study is a helpful source of information for market players, investors, VPs, stakeholders, and new entrants to gain thorough understanding of the industry and determine steps to be taken to gain competitive advantage. Download Free Sample Report:   https://dpiresearch.com/request-a-free-sample-report/ The United States market for the insulin injection pen market is expected to touch US$ 5.5 billion by the year-end of 2027. Report Scope: An Insightful Analysis of the United States Diabetes Population and Forecast to 2027 Delivers a Complete Overview of the United States Insulin Users and Forecast to 2027 The United States Insulin Injection Pen Market Size and Forecast (2015 – 2027) The United States Insulin Injection Pen Market Share &